Becton Dickinson's Q3 Revenues Rise 3 Percent on Bioscience Gains

BD's revenues, which were up around 9 percent on a currency-neutral basis, were up in both the US and international markets. The firm's bioscience business had a particularly strong quarter in the US.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories